Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ophthalmic Findings in Danish Fabry Patients on Enzyme Replacement Therapy
NCT01997489Phase 4Completed
- Sponsor
- Rigshospitalet
- Start
- Sep 2001
- Primary completion
- Sep 2013
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of agalsidase alfa, agalsidase beta in Fabry disease (FD), sponsored by Rigshospitalet. Started Sep 2001; status: completed.
02
Drugs
agalsidase alfaagalsidase beta
03
Conditions
Fabry disease (FD)
Beyond the preview
Go deeper on NCT01997489.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01997489.